johnsonjohnson
On Tuesday, Johnson & Johnson petitioned the U.S. Food and Drug Administration (FDA) to authorize a booster shot of its COVID-19 vaccine. J&J had previously revealed an internal study Monday that showed a second shot administered two months after the first shot improved immunity against symptomatic moderate to severe symptoms to COVID to 94 percent. “A booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent,” said Mathai Mammen, who’s in charge of the global R&D division at J&J’s Janssen. “At the same time, we continue to...
uPolitics.com
The Food and Drug Administration and the Centers for Disease Control and Prevention announced Friday that vaccine providers can restart their use of Johnson & Johnson’s COVID19 vaccine. The vaccine rollout has been on hold for ten days due to the six reported cases of severe blood clots among the 6.8 million shots administered. However, the decision to lift the pause was expected, as FDA revealed last week that their decision to pause the J&J vaccine was “out of an abundance of caution.” With an approval from federal health officials, the U.S. is expected to resume using Johnson & Johnson’s va...
uPolitics.com
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら